| M |
|
Macromolecular Substrate-Binding Exosites on Both the Heavy and the Light Chain of Factor XIa Mediate the Formation of the Michaelis Complex Required for Factor IX-Activation
|
| Sinha D, Marcinkiewicz M, Miller TN, Walsh PN |
| |
|
Macrophage Expression of Active MMP-9 Is Sufficient to Induce Plaque Rupture in ApoE–/– Mice
|
| Gough PJ, Wille PT, Wilson CL, Tang J, Raines EW |
| |
|
Macrophage Gene Expression Appears to Differ between AGE and OxLDL Stimulation
|
| Martin J, Collot-Teixeira S, Bultelle F, Ristagno A, McGregor JL |
| |
|
Macrophage-neutrophil Cross Talk During Pulmonary Exposure to Silica Particles Triggers Peripheral Platelet Activation Via Elastase
|
| Nemmar A, Nemery B, Vermylen J, Hoylaerts MF |
| |
|
Magnesium Sulfate in Doses Up to 8-Fold Greater than Physiologic Concentration does Not Affect TPA-Mediated Clot Lysis: An in vitro Study
|
| Stewart D, Marder VJ, Saver JL |
| |
|
Malaria Infection Induced Thrombocytopenia Is not Related to Systemic Platelet Activation
|
| van Heerde WL, Jacobs N, McCall M, Hermsen CC, Sauerwein RW, van de Ven AJAM |
| |
|
Management of Anticoagulated Patients Undergoing Dental Treatment
|
| Madhani M, MacCallum PK, Ferris NML, Djemal S, Duggan C |
| |
|
Management of Asymptomatic Catheter-related Thrombosis in Children with Acute Lymphoblastic Leukemia (ALL): A Survey of Clinical Practice
|
| Journeycake JM, Winick NJ, Buchanan GR |
| |
|
Management of Glanzmann's Thrombasthenia Surgery: Contribution of Thrombelastogram (ROTEM®)
|
| Dutrillaux F, de Maistre E, Volot F, Wessels C, Filipuzzi L, Lorenzini JL |
| |
|
Management of Heparin-Induced Thrombocytopenia Including Thrombosis, Cardio-Pulmonary-Bypass and the Use of New Drugs
|
|
| |
|
Management of Injecting Drug Users (IDU) with Deep Vein Thrombosis (DVT): A Delphi Study
|
| Dawson DJ, Russell M, Mackway-Jones K, Shiach CR, Peters L |
| |
|
Management of the Patients on Long Term Oral Anticoagulant Treatment (OAT) Undergoing Elective Surgery: Experience of the Italian Anticoagulation Clinics
|
| Baudo F, Mostarda G, Ghirarduzzi A, Molinatti M, Pengo V, Poli D, Tosetto A, Tiraferri E, Morra E |
| |
|
Management of VTE in the Outpatient Setting: Findings from a UK Prospective Outpatient Treatment Registry (VERITY)
|
| O'Shaughnessy D, Rose P, Pressley F, Scriven N, Arya R, Amlot N, on behalf of the VERITY investigators |
| |
|
Management Studies Using a Combination of D-Dimer Test Result and Clinical Probability to Rule Out Venous Thromboembolism; A Systematic Review
|
| ten Cate-Hoek AJ, Prins MH |
| |
|
Management Study with the New HemosIL™ D-Dimer HS For Exclusion of Venous Thromboembolism (VTE)
|
| Arnout J, Sales M, Arza B, Sánchez T, Serra J, de Moerloose P |
| |
|
Manifestations of the Antiphospholipid Syndrome in Patients with Malignancies
|
| Miesbach W, Putz B, Asmalash G, Scharrer I |
| |
|
MAP-Kinase/NF-kB-Dependent Endothelial Activation and Inhibition of PI3-kinase/Nitric Oxide Are Both Involved in Pro-Atherogenic Effects of Insulin – A Link to the Pathogenesis of Accelerated Atherosclerosis in Diabetes
|
| Madonna R, Massaro M, Pandolfi A, Consoli A, De Caterina R |
| |
|
Mapping of B Cell Epitopes on the Factor VIII C2 Domain
|
| Pratt KP, Jacquemin M, Shima MK, Davie EW, Thompson AR |
| |
|
Marginal Effect of Interference of Simvastatin on Clopidogrel Antiplatelet Effectiveness Assessed by Measures of Platelet Activation and Aggregation
|
| Ahnadi CE, Lepage S, Leclair C, Grant A |
| |
|
Markers of Vascular Inflammation Are Associated with the Degree of Atherosclerosis Assessed as Angiographic Score and Treadmill Walking Distance in Patients with Peripheral Arterial Occlusive Disease
|
| Nylænde M, Kroese A, Stranden E, Morken B, Sandbæk G, Lindahl AK, Arnesen H, Seljeflot I |
| |
|
Massive Sinus Thrombosis in a Six-Year-Old Girl: Acute Management and Identification of a Possible New Hypercoagulable State
|
| Grabowski EF, Buonanno FS, Jones RM, Van Cott EM, Rabinow JD, Grant PE, Butler WE |
| |
|
Matrix Metalloproteinases and Markers of Thrombin Generation in Patients with Restenosis after Percutaneous Coronary Interventions
|
| Zemlyanskaya O, Panchenko E, Dobrovolsky A, Samko A, Levitskiy I, Titaeva E, Masenko V |
| |
|
Maximal Platelet Accumulation, But Not Fibrin Deposition, Is Dependent on Protease-Activated Receptor 4 in a Mouse Model of Thrombosis
|
| Vandendries ER, Hamilton JR, Coughlin SR, Furie BC, Furie B |
| |
|
May-Thurner Syndrome (Ileofemoral Vein Thrombosis) in Adolescents with Additional Thrombophilic Risk Factors
|
| Raffini L, Raybaykar D, Blumenstein M, Manno C |
| |
|
Measurement of EQA Performance of a Whole Blood D-Dimer Assay Using Lyophilized Plasma
|
| Raby A, Crowther M, Gun-Munro J, Richardson H |
| |
|
Measurement of Hirudin and Synthetic Thrombin Inhibitors in Plasma with a New Clotting Method, without Interference of Clotting Factor Levels
|
| Vissac AM, Amiral J |
| |
|
Measurement of Plasma Selectin Levels in Patients with Antiphospholipid Syndrome
|
| Song K, Song J |
| |
|
Measurement of Platelet Function in Response to 3 Common Antiplatelet Regimens in Patients with Peripheral Occlusive Arterial Disease (POAD)
|
| Morel-Kopp M-C, Wong S, Chen Q, Ward CM, Lewis D |
| |
|
Measurement of Von Willebrand Activity Using an Automated Latex Agglutination Technique Adapted for Use on the STA-Compact Coagulation Analayser
|
| Ivey L, Hansen L |
| |
|
Measurements of Soluble Thrombomodulin Activity and Antigen: Factors Contributing to Variance and Potential for Identification of Protein Variants
|
| Ohlin AK, Konstantoulas CJ, Humphries SE, Goodall AH, Hogwood J, Esmon CT, Toh C-H, Mather H, Ireland H |
| |
|
Measuring Concentration of Soluble Fibrinogen and Fibronectin Complexes (FG-FN) in Patient' Plasma with Various Diseases Using Two-Step Sandwich ELISA Method
|
| Magari Y, Shibata T, Ichinose A |
| |
|
Measuring Fragment 1 + 2 in Spot Urine to Determine the Thrombotic Potential after Hip Arthroplasty
|
| Ryge C, Lassen MR, Borris LC, Solgaard S, Breindahl M, Sonne S |
| |
|
Measuring Thrombin Generation as a General Parameter in Relation to Single Coagulation Tests
|
| Siegemund T, Siegemund A, Petros S, Scholz U, Henckel T, Engelmann L |
| |
|
Measuring Thrombin Generation as Marker of Hypercoagulation in Patients with Lung Cancer
|
| Siegemund A, Siegemund T, Kreymborg-Grosse K, Seyfarth H-J, Henckel T, Wirtz H |
| |
|
Mechanism for the Inhibitory Effect of Tetramethylpyrazine on the Expression of Tissue Factor Induced by Tumor Necrosis Factor in ECV304 Cells
|
| Xiong SL, Wen ZB, He XF, He SL |
| |
|
Mechanism of Activation of Tissue Factor
|
| Chen VMY, Ruf W, Hogg PJ |
| |
|
Mechanism of HKa-induced Endothelial Cell Apoptosis
|
| Sun D, Matsuyama S, McCrae KR |
| |
|
Mechanism of Lipopolysaccharide-induced Decrease of Plasma Protein S: Its Expression in Hepatocytes and Sinusoidal Endothelial Cells Is Mediated by NFkB Activation
|
| Hayashi T, Kishiwada M, Fujii K, Yuasa H, Nishioka J, Gabazza EC, Suzuki K |
| |
|
Mechanisms of Cancer-Induced Thrombosis
|
|
| |
|
Mechanisms of Homocysteine-Induced Atherothrombosis
|
| Lentz SR |
| |
|
Mechanisms of Thrombin Generation Induced by High Concentrations of Recombinant Factor VIIa
|
| Livnat T, Zivelin A, Martinowitz U, Salomon O, Seligsohn U |
| |
|
Medroxyprogesterone Acetate-associated Relapse of Thrombotic Thrombocytopenic Purpura
|
| Chakravarthi P, Bilgrami SA |
| |
|
Mesenteric Vein Thrombosis: the Etiologic Spectrum of a Unique Thrombotic Disorder
|
| Thatipelli MR, Wysokinski WE, McBane RD |
| |
|
Metabolic Arrest Suppresses Platelet Binding to and Phagocytosis by Macrophages
|
| Badlou BA, Wu Y, Martin JWI, Smid WM, Akkerman JWN |
| |
|
Metabolism of Arachidonic Acid through 12-LOX in Platelets May Account for Transient Aspirin Resistance Linked to Treatment with Heparin
|
| Webster SE, Jones CI, Payne DA, Hayes PD, Naylor AR, Goodall AH |
| |
|
Methodological Issues Which May Influence the Detection, Quantitation and Functional Assessment of Platelet-Derived Microparticles
|
| Connor DE, Exner T, Ma DDF, Joseph JE |
| |
|
Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism and Plasma Levels of Homocysteine in Patients with Type 2 Diabetes
|
| Soares AL, Carvalho MG, Fernandes AP, Sousa MO, Lasmar MC, Garcia ML, Novelli BA, Dusse LMS, Vieira LM, Lages GFG, Cardoso JE |
| |
|
Methyl-Methacrylate Bone Cement Surface Does Not Promote Platelet Aggregation or Plasma Coagulation in vitro
|
| Blinc A, Bozic M, Vengust R, Stegnar M |
| |
|
Mice Lacking Gas6 are Protected from Graft-Versus-Host Disease in the Liver Due to a Reduced Activation of the Endothelium
|
| Burnier L, Herbert J-M, Savi P, Collen D, Conway EM, Carmeliet P, Izui S, Angelillo-Scherrer A |
| |
|
Mice Lacking the Platelet Glycoprotein Ib Beta Intracellular Domain Display Resistance to Thrombosis But Normal Bleeding Times
|
| Strassel C, Nonne C, Eckly A, David T, Freund M, Cazenave J-P, Gachet C, Lanza F |
| |
|
Miconazole Oral Gel and Nystatin Solution Potentiates Warfarin Anticoagulant Activity
|
| Kovac M, Mikovic D, Maslac A |
| |
|
Microarray Analysis of Prothrombin Knockdown in Zebrafish
|
| Pudur J |
| |
|
Microarray Analysis on Platelet RNA of a Patient with a 22q11 Microdeletion Including the Gpibbeta Gene and Associating Digeorge Syndrome, Moderate Thrombocytopenia and Large Platelets
|
| Nurden P, Mattei MG, Combrié R, Luciani J, Nurden A, Tronick-Le Roux D |
| |
|
Microparticle-associated P-selectin Is a Marker of Platelet Activation in Preeclampsia
|
| Lok C, Nieuwland R, Hau C, VanderPost J, Boer K, Van Bavel E, Sturk A |
| |
|
Microparticles From Preeclamptic Patients Do Not Affect Transcription of Inflammation-related Genes in Endothelial Cells
|
| Lok C, Böing A, Reitsma P, VanderPost J, Van Bavel E, Boer K, Sturk A, Nieuwland R |
| |
|
Microparticles from Smooth Muscle Cells Induce Endothelial Dysfunction, a Phenomenon Prevented by Glycoprotein IIb/IIIa Antagonists
|
| Essayagh S, Brisset AC, Terrisse AD, Dupouy D, Tellier L, Navarro C, Arnal JF, Sié P |
| |
|
Microvessel Hemostasis Is Inhibited by Medicinal Leech Salivary Gland Secretion
|
| Baskova I, Zavalova L |
| |
|
MIP-1b and VE-Cadherin Are Implicated in Acute Rejection in Human Heart Transplantation
|
| Roussoulières ALS, Raisky O, Chalabreysse L, Cerutti C, Dureau G, Boissonnat P, Sebbag L, Obadia J-F, Ninet J, Bastien O, Thivolet-Bejui F, McGregor JL |
| |
|
Modeling VWF Catabolism Predicts the Multimer Pattern and Subunit Degradation in VWD Vicenza, Type 1, Type 2A, and Healthy Controls after DDAVP Infusion
|
| Gézsi A, Mohl A, Sallai K, Nagy E, Szabó T, Sadler JE, Bodó I |
| |
|
Modified Antiplatelet Action of Atorvastatin in 3'UTR/T LOX-1 Polymorphism Carriers
|
| Puccetti L, Bruni F, Pasqui AL, Pastorelli M, Palazzuoli A, Cercignani M, Ciani F, Ghezzi A, Auteri A |
| |
|
Modified Human Recombinant HPA-1a Antibodies Inhibit Platelet Binding and Monocyte Activation by Polyclonal Anti-HPA-1a Sera
|
| Ghevaert C, Turner C, Armour K, Clark M, Hadley A, Ouwehand W, Williamson L |
| |
|
Modified Whole Blood Clotting Time Assay Detects Recombinant Human FVIIa and rFVIIa Analog NN1731 in Canine Hemophilia a Blood in a Dose-Dependent Fashion
|
| Merricks EP, Ezban M, Persson E, Raymer RA, Dillow A, McCorquodale S, Nichols TC |
| |
|
Modulating Murine Platelet Function by Expressing Integrin aIIbb3 Locked-In Its High Affinity State
|
| Wilcox DA, Fang J, Johnson BD, Valentin N |
| |
|
Modulation of Angiogenesis during Adipose Tissue Development in Murine Models of Obesity
|
| Lijnen HR, Voros G, Demeulemeester D, Collen D |
| |
|
Modulation of Endothelial Protein C Receptor (EPCR)-Dependent Protein C Activation and Activated Protein C Cytoprotective Activity By Platelet Factor 4
|
| Mosnier LO, Ochoa RL, Griffin JH |
| |
|
Modulation of Fibrinolysis by Some Components Present in Arterial Thrombus
|
| Kolev K, Váradi B, Machovich R |
| |
|
Modulation of Inflammatory Markers after Treatment with Topically Administered Mucopolysaccharide Polysulfate. Results of a Study in Primates
|
| Raake W, Hoppensteadt D, Schultz C, Neville B, Fareed J |
| |
|
Modulation of Monocyte Function by Activated Protein C, a Natural Anticoagulant
|
| Toltl L, Stephenson DA, Beaudin S, Liaw P |
| |
|
Modulation of Platelet Adhesion by Antithrombin
|
| Loncar R, Stoldt V, Thomas V, Zotz RB, Scharf RE |
| |
|
Modulation of Protease Nexin-1 Activity by Polysaccharides
|
| Richard B, Bouton MC, Letourneur D, Jandrot-Perrus M, Arocas V |
| |
|
Modulation of Von Willebrand Factor A1 Domain-Mediated Platelet Aggregation by a-Thrombin
|
| Mendolicchio GL, Celikel R, Varughese KI, Savage B, Ruggeri ZM |
| |
|
Molar Specific Activity of Factor VIII: An Alternative Means of Comparing FVIII Concentrates
|
| Jankowski M, Weston S, Patel H, Sharpe P |
| |
|
Molecular Analysis of Two Unrelated Patients with Bernard-Soulier Syndrome – Identification of Novel Mutation in Glycoprotein Ib Alpha Gene
|
| Ozelo MC, Siqueira LH, De Paula EV, Machado TF, Costa FF, Annichino-Bizzacchi JM |
| |
|
Molecular Basis of MYH9-Related Disorders in a Series of Ten Families
|
| Schlegel N, Bardet V, Gerard B, Azibi K, Bellucci S, Boinot C, Cramer E, Deville A, Dreyfus M, Fenneteau O, Hurtaud-Roux MF, Latger-Cannard V, Leblanc T, Loirat C, Nurden P |
| |
|
Molecular Characterization in an Italian Patient with Plasminogen Deficiency And Ligneous Conjunctivitis
|
| Siboni SM, Spreafico M, Menegatti M, Martinelli I, Peyvandi F |
| |
|
Molecular Characterization of a 4.4 Mbp Deletion of the X Chromosome in a Male with Hemophilia B
|
| Hewitt J, Chou E, Smith VC, Brown L, Huntsman DG, Brown C, Yong S-L, Wadsworth LD, Wu J, MacGillivray RTA |
| |
|
Molecular Characterization of Haemophilia B: 17 Novel Mutations in Patients of Indian Origin
|
| Jayandharan G, Shaji RV, Nair SC, Viswabandya A, Mathews V, George B, Chandy M, Srivastava A |
| |
|
Molecular Characterization of Plasminogen Activator Inhibitor-1 (PAI-1)/Thrombin Inhibition in the Absence and Presence of Heparin and Vitronectin (VN)
|
| Fortenberry YM, Rau JC, Cranford LC, Myles T, Leung LLK, Church FC |
| |
|
Molecular Cloning of 20-kDa Myosin Light Chain Isoforms in Human Platelets
|
| Miyazaki K, Watanabe M, Ikebe M, Mohri H, Higashihara M |
| |
|
Molecular Cloning of Novel Vascular Endothelial Growth Factors from Snake Venoms
|
| Matsunaga Y, Yamazaki Y, Morita T |
| |
|
Molecular Composition of Soluble Fibrin at Various Diseases and Fibrinolysis Products Reacting with D-dimer-Specific Monoclonal Antibody III-3b
|
| Gritsenko PG, Lugovskaya NE, Lugovskoy EV, Kolesnikova IN, Komisarenko SV |
| |
|
Molecular Defect of Factor XIII A Subunit in Newfoundland Families with Factor XIII A Subunit Deficiency
|
| Zheng H, Cui J, Scully M-F, Macgregor D, Hendry M, Harvey M, Xie Y-G |
| |
|
Molecular Dissection of Platelet Production Via Random Mutagenesis
|
| Alexander WS, Carpinelli M, Metcalf D, Stevenson W, Antonchuk J, Majewski I, Hyland C, Viney E, Hilton A, Corbin J, Roberts AW, Nicola NA, Hilton DJ |
| |
|
Molecular Mechanism and Functional Implications of Thrombin-Mediated Tyrosine Phosphorylation of PKCd in Platelets
|
| Murugappan S, Shankar H, Dorsam RT, Jin J, Kunapuli SP |
| |
|
Molecular Mechanisms Involved in the Resistance of Fibrin to Clot Lysis in Subjects with Type 2 Diabetes Mellitus
|
| Dunn EJ, Ariëns RAS, Philippou H, Grant PJ |
| |
|
Molecular Mechanisms of Thrombin-Mediated Fibrin Assembly
|
| Medved L, Yakovlev S, Pechik I |
| |
|
Molecular Models of the Prothrombinase Complex
|
| Adams TE, Mann KG, Everse SJ |
| |
|
Molecular Pathogenesis of Type 1 von Willebrand Disease (VWD) – A UK National Study
|
| Grundy P, Cumming A, Keeney S, Collins P, Bowen D, Lester W, Enayat S, Guilliatt A, Pasi J, Keeling D, Hay C, Hill F |
| |
|
Molecular Pathology of Haemophilia B in 19 Unrelated Han's Patients: Identification of Five Novel Mutations
|
| Dai J, Liu XF, Wang XF, Ding QL, Wang HL |
| |
|
Molecular Pathways for Lymphangiogenesis and Their Role in Human Disease
|
| Stacker SA, Caesar C, Inder R, Baldwin M, McColl B, Roufail S, Williams R, Hughes T, Alitalo K, Achen MG |
| |
|
Molecular Pathways Involved in Thrombus Formation in vivo after FeCl3 or Laser-Induced Injury
|
| Dubois C, Panicot-Dubois L, Furie B, Furie BC |
| |
|
Molecular Recognition Mechanisms of Thrombin
|
| Huntington JA |
| |
|
Molecular Studies in Patients with Type 3 and Type 1 Von Willebrand Disease. New Candidate Mutations
|
| Cabrera N, Casaña P, Cid AR, Haya S, Lerma MA, Cortina V, Aznar JA |
| |
|
Monitoring Different Hemostasis Reactions (Chronometric, Chromogenic and Immunoturbidimetric), Using CCD Technology Based Sensor
|
| Pagès J, Alentorn F, González B, Torres S, Pomar P |
| |
|
Monitoring Haemostasis in Cardiopulmonary Bypass in Children – Measures of Heparin Activity
|
| Ignjatovic V, Monagle P, Cochrane A, Furmedge J, Than J, Bennett M, Horton S |
| |
|
Monitoring International Normalized Ratio (INR) in Patients with Chronic Non-Valvular Atrial Fibrillation: Relationships between INR and Adverse Outcomes?
|
| Bullano MF, Sarawate C, Willey VJ, Sikirica MV, Hauch O |
| |
|
Monitoring of Aspirin and Clopidogrel Response in Patients with Arterial Occlusive Disease with Different Platelet Function Methods
|
| Mani H, Luxembourg B, Klaeffling C, Lindhoff-Last E |
| |
|
Monitoring of D-Dimer and Anti-Xa Activity in 43 Women Treated with Dalteparin During Pregnancy
|
| Mondorf C, Mondorf W |
| |
|
Monitoring of Heparinization during Extracorporeal Circulation (ECC) with the New Anti-Factor Xa (FXa) Point-of-Care (POC) Clotting Assay Heptest-POC-Hi™
|
| Haubelt H, Simon M, Bach J, Isgro F, Saggau W, Hellstern P |
| |
|
Monitoring of P2Y12 Receptor Antagonist Efficacy
|
| Smith SMG, Judge H, Peters G, Storey RF |
| |
|
Monocyte Recruitment and Increased Urokinase (uPA) Activity are Important for Thrombus Resolution
|
| Gossage JA, Humphries J, Modarai B, Eastham D, Smith A, Burnand K |
| |
|
Monocyte Subsets in Early Atherosclerosis – Lessons Learnt at Home
|
| Heine GH, Ulrich C, Blömer L, Oster K, Rogacev K, Grenner Y, Schlitt A, Geisel J, Köhler H, Girndt M |
| |
|
Monocytes and Plasma Tissue Factor Levels in Normal Individuals and Patients with Lower-Limbs Deep Venous Thrombosis: Potential Diagnostic Tools?
|
| Vieira LM, Martins Filho OA, Dusse LMS, Bastos M, Ferreira MFR, Lwaleed BA, Fernandes AP, Carvalho MG |
| |
|
More Carotid Atherosclerosis in HCV Positive Italian Patients?
|
| Boddi M, Chellini B, Marcucci R, Fedi S, Rogolino A, PriscoAbbate DR, Gensini GF, Solazzo V, Zignego AL |
| |
|
MORGAM – An International Pooling of Cardiovascular Cohorts to Investigate Risk Profiles of Arterial Thrombosis
|
| Salomaa V |
| |
|
Mortality Prediction Using Coagulation Parameters in Patients with Sepsis: The New Overt DIC Scoring System in Comparison with APACHE II and LOD Score
|
| Angstwurm MWA, Dempfle CE, Spannagl M |
| |
|
MTHFR C677T and the Risk Of Venous Thrombosis – Interaction with Factor V Leiden and Prothrombin G20210A Mutations
|
| Bezemer ID, Doggen CJM, Vos HL, Rosendaal FR |
| |
|
MTHFR C677T Polymorphism is Associated with Low Levels of Folic Acid in the InChianti Study
|
| Gori AM, Corsi AM, Alessandrello, Liotta A, Falciani M, Mannini L, Brogi D, Bandinelli B, Fedi S, Fatini C, Ferrucci L, Abbate R, Gensini GF |
| |
|
Multi Modal Management of Purpura Fulminans due to Homozygous Protein C Deficiency
|
| Monagle P, Ignjatovic V, Newall F, Savoia H, Campbell J, Barnes C, Hardikar W, Smith A |
| |
|
Multicenter Evaluation of a New ELISA for the Determination of Prothrombin Fragment F 1+2
|
| Merz M, Eidam A, Braun S, Kemkes-Matthes B, Trobisch H, Rott H, Engelhardt W |
| |
|
Multicenter Evaluation of BCS® XP – A Further Development of the Widespread BCS® Coagulation Analyzer
|
| Gringel E, Hafner G, Katz N, Kretschmer V, Lackner KJ, Peetz D, Steigerwald U, Stolz H, Tabesch R, Weippert-Kretschmer M, Engelhardt W |
| |
|
Multi-detector Row Computed Tomography in Outpatients with Suspected Pulmonary Embolism
|
| Perrier A, Roy PM, Sanchez O, Le Gal G, Meyer G, Gourdier AL, Furber A, Revel MP, Howarth N, Davido A, Bounameaux H |
| |
|
Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
|
| Budde U, Schneppenheim R, Will K, Peake I, Goodeve A, Rodeghiero F, Castaman G, Federici A, Batlle J, Meyer D, Mazurier C, Goudemand J, Eikenboom J, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F |
| |
|
Multiple Mechanisms for S. Aureus and S. Epidermidis Platelet Activation
|
| Brennan MP, Foster TJ, Cox D |
| |
|
Multi-Site Comparison of Platelet Function Testing
|
| Miller CH, Dowling N, Kouides PA, Philipp CS, Stein SF, Kulkarni R, Lukes A, Crudder S |
| |
|
Multivalent Circular Aptamers: Therapeutic Candidates for Vascular Indications
|
| King GC, Di Giusto DA, Aung MT |
| |
|
Murine and Human ADAMTS13 Swap Mutants Shed a New Light on the Molecular Mechanism of the ADAMTS13-VWF Interaction
|
| Fuhrmann J, Plaimauer B, Scheiflinger F |
| |
|
Murine Hemophilia A is Phenotypically Corrected by Platelet-Expressed Factor VIII Even in the Absence of Detectable Plasma FVIII
|
| Shi Q, Wilcox DA, Fahs SA, Fang J, Johnson BD, Weiler H, Montgomery RR |
| |
|
Muscular Crushing-‘Thrombotic Disorder’ of the Injured Limb
|
| Lupescu O, Nagea M, Nedelcu DE |
| |
|
Mutagenesis Studies toward Understanding the Mechanism of Cofactor Function of Thrombomodulin in Promoting Protein C Activation by Thrombin
|
| Rezaie A, Yang L |
| |
|
Mutation Analysis of the Factor VIII Gene in 224 Iranian Families with Haemophilia A
|
| Rastegar Lari G, Baghaipoor MR, Fard P, Rassoulzadegan M, Ravanbod S, Jazebi M, Enayat MS, Lavergne JM, Ala FA |
| |
|
Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
|
| Goodeve A, Hashemi M, Castaman G, Baronciani L, Oyen F, Dudlova J, Halder C, Guilliatt A, Peake I, Rodeghiero F, Federici A, Batlle J, Meyer D, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Holmberg L, Lethagen S, Pasi J, Hill F |
| |
|
Mutational Analysis of the Kunitz Protease Inhibitor (KPI) Domain of Protease Nexin-2 (PN2) Reveals Specificity for Regulation of Factor XIa (FXIa) in Contrast to Other Coagulation Target Proteases
|
| Navaneetham D, Walsh PN |
| |
|
Mutational Spectrum of Severe Hemophilia A in A Reference Congenital Coagulopathies Unit: Detection of New Molecular Defects
|
| Casaña P, Cabrera N, Haya S, Cid AR, Lerma MA, Cortina V, Aznar JA |
| |
|
Mutations Causing Type 3 Von Willebrand Disease in a Small Cohort of Greek Patients
|
| Adamtziki E, Oyen F, Theodosiadis G, Kapsimali Z, Aronis S, Schneppenheim R |
| |
|
Mutations in Homozygotes and Compound Heterozygotes with FXII Deficiency
|
| Lombardi AM, Fabris F, Bortoletto E, Sartori MT, Vettore S, Girolami A |
| |
|
Mutations in the Protein C Binding Site of Factor VIII Lead to the Resistance of Activated Protein C Cleavage
|
| Enjolras N, Rolli V, Ducasse C, Rodriguez M-H, Weimer T, Hauser H-P, Négrier C, Plantier J-L |
| |
|
Mutations in the VKORC1 Gene Cause Warfarin Resistance, Warfarin Sensitivity and Combined Deficiency of Vitamin K Dependent Coagulation Factors
|
| Oldenburg J, Rost S, Geisen C, Fregin A, Ivaskevicius V, Seifried E, Scharrer I, Heistinger M, Tuddenham EGD, Müller CR, Zieger B |
| |
